Research Funding FPWR has funded over $10M in Prader-Willi syndrome research, indicating a strong grant-making operation and a potential for partnerships with nonprofits and pharma to co-fund trials or access researchers for clinical studies.

Collaborations & Partners Active collaborations with research institutions, pharmaceutical companies, and regulatory bodies (FDA) suggest FPWR is open to sponsored research, data sharing, and consortia efforts that could align with drug development and biomarker work.

Global Registry The launch of the Global Schaaf-Yang Syndrome Registry demonstrates FPWR’s capability to manage large-scale patient registries and data collection, presenting opportunities for data services, analytics, and patient recruitment for trials.

Strategic Alliances Past partnerships with biopharma (e.g., Palobiofarma) and disease-focused organizations indicate FPWR is receptive to collaboration and co-development programs that could include open-label studies, disease biology research, or technology-driven solutions.

Fundraising & Growth With revenue in the range of $10M-$25M and multiple grant rounds, FPWR demonstrates a scalable non-profit funding model that could benefit from technology enablement (CRM, analytics, donor engagement) and services to optimize fundraising operations.